High-Tech Injection Moulding Manufacturer Adds to Management Team

Plastic Design Corporation, a Vance Street Capital portfolio company, is excited to announce Jeff Kyle has been appointed CEO of Plastic Design Corporation (PDC), effective immediately.

Mr. Kyle has nearly 25 years of experience in the medical device industry, including senior leadership roles in product development, engineering, and manufacturing. He brings extensive experience partnering with prominent life science, medical device, and pharmaceutical companies throughout the product life cycle, from design and development through commercialization and sustaining. Prior to joining PDC, he held senior roles at West Pharmaceutical Services, Pall Corporation & Beckman Coulter where he was most recently responsible for development of proprietary drug delivery systems. Mr. Kyle has a MBA from the University of Michigan and a BS in Mechanical Engineering from MIT.

Mark Kinder, founder of PDC, will continue to support the business in an advisory capacity, focusing in areas such as strategic planning, technology development and opportunity assessment of new markets and customers. Additionally, Mr. Kinder will play in pivotal role as the company enters into its next stage of growth, providing his vast depth of knowledge and experience in support of the transition to the new leadership team. “PDC’s future is in great hands with Jeff joining as the new CEO. Jeff’s industry experience, strong technical background and his focus on operational excellence will benefit the entire organization” said PDC’s founder, Mark Kinder.

With the recent investment by Vance Street Capital, PDC has added additional engineering resources to increase production capacity to scale both development services and contract manufacturing.

“Jeff has an extensive high-tech injection moulding background. With his engineering perspective and deep understanding of the complexities in the product development life cycle he will be vital to customers as they face the challenges of advancing new life saving devices,” said Michael Janish, managing partner at Vance Street Capital.

Please join us in congratulating Jeff on his role!